Drug-licensed pharmaceutical marketing with an expanding nutraceutical pipeline — from prescription cardio-metabolic formulations to preventive health supplements distributed nationally.
The Pharmaceuticals & Nutraceuticals division operates through Waystar Life Sciences, a Karnataka drug-licensed marketing and distribution entity holding licences KA-B31-267984 and KA-B31-267983.
The current portfolio spans cardio-metabolic prescription products and OTC bone-health nutraceuticals, with active distribution on national platforms including Tata 1mg. A structured pipeline of new formulations is in development through Waystar Incubator, applying a distribution-first commercialisation thesis.
Waystar Life Sciences holds Karnataka Drug Licences and markets a curated portfolio of prescription and over-the-counter products. Actively distributing on Tata 1mg and through traditional pharma channels, with institutional physician marketing through hospital sales representatives.
Enquire About Distribution →Full Karnataka State Drug Licensing compliance. Products marketed under valid manufacturing and wholesale drug licences with active GST registration and ERP-managed regulatory documentation.
Multi-channel distribution covering e-pharmacy (Tata 1mg Fulfilled-by-1mg programme), traditional wholesale-retail pharmacy chains, and direct institutional sales across Karnataka.
Structured medical representative programme with hospital-level visit tracking, physician information materials, and digital outreach including WhatsApp-based doctor engagement collateral.
Active nutraceutical pipeline in development through Waystar Incubator — including Omega-3 fatty acid formulations — applying a distribution-first thesis where channel access precedes product launch.
Wholesale, institutional, and e-pharmacy partnership enquiries for Waystar Life Sciences products.